Project Number ARUK-SRF2018B-004 Agency/Funding Organization Alzheimer's Research UK Funding Year 2018 View Full Project Details for Noradrenergic treatment for the symptoms of Alzheimer's disase. Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category A. Molecular Pathogenesis and Physiology of Alzheimer's Disease and Alzheimer's Disease-related Dementias (AD/ADRDs) 12. Neuroendocrine Mechanisms c. Stress Hormones/HPA Axis Researcher and Organization Principal Investigator Dorothea Hammerer Principal Investigator First Name Dorothea Principal Investigator Last Name Hammerer Awardee Organization University College London Contact PI Country United Kingdom Project Detail FY Overall Cost $419,428 Funding Organization Agency/Funding Organization Alzheimer's Research UK Funding Organization Country United Kingdom
